UNDERCOVER RECORDING RAISES SERIOUS CONCERNS ABOUT REMOTE SALES OF HIGH-COST STEM-CELL TREATMENTS

February 5, 2026

Share this article

An analysis of a recorded telephone call with a non-medical sales representative

An undercover recording obtained as part of an independent investigation has raised serious concerns about how an expensive regenerative treatment was promoted to a prospective patient — without any medical consultation and by an individual who is not a doctor.


The recording captures a telephone conversation between an undercover operative (UC), based in the United States, and Andrew Chancellor (AC), who was acting on behalf of Wellbeing International Foundation Ltd.

During the call, AC discusses a proposed treatment costing $48,000, outlines how it would be delivered, and provides detailed medical claims — despite not being a qualified medical practitioner.


No consultation, no treating doctor involved


According to the recording, the entire interaction took place by telephone. At no point did AC advise the undercover operative to undergo a medical consultation with a doctor prior to treatment.

Nor did AC suggest involving the UC’s own physician.

Instead, AC states that the company could “find a doctor” to administer the treatment intravenously, distancing the procedure from the patient’s existing medical care.


In one key exchange, AC says:

“Well not your doctor, we can find a doctor for you, puts it into you intravenously.”

Experts later told this investigation that such a statement is significant, as it suggests awareness that a patient’s own doctor may be unwilling to administer the proposed procedure.


Medical claims made by a non-doctor


During the call, AC explains the treatment in highly technical terms, describing a process involving stem cells, laboratory manipulation, and the production of extracellular vesicles (EVs).


In the recording, AC claims that:

  • stem cells would be taken from the patient’s blood
  • the cells would be “grown” and placed under oxygen deprivation
  • this process would generate billions of extracellular vesicles
  • these vesicles would then be infused intravenously
  • the vesicles would “seek out damage,” destroy dead cells, repair scar tissue, and improve inflammation


AC also suggests the treatment would reduce pain and improve function within “three to six weeks.”

These claims were made despite AC confirming neither a physical examination nor any form of medical assessment had taken place.


Logistics arranged without medical oversight


The recording further reveals that AC told the UC the treatment could be arranged almost anywhere, including the United States.


AC explains that:

  • approximately 140–150ml of blood would be taken
  • the blood would be shipped to a laboratory
  • the processed material would later be infused intravenously


In a later email reviewed as part of the investigation, AC states that he could arrange for the blood to be taken at the patient’s home address.

Experts consulted for this investigation said that arranging blood collection and intravenous treatment in this manner, without documented medical oversight, raises significant safety and regulatory concerns.


Payment discussed before medical assessment


The conversation also includes a discussion of payment before any consultation or clinical review.

When asked about cost, AC states:


“The total cost to get all of this done and to have two treatments is $48,000.”

When asked about payment method, AC advises a direct bank transfer to a US bank account.

At no point in the call does AC discuss medical risks, alternative treatments, contraindications, or the need for informed consent.


Expert concerns


Independent experts who reviewed the transcript said the call raises multiple red flags.

They noted:

  • medical claims being made by a non-doctor
  • absence of a consultation or diagnostic process
  • discouragement of involvement from the patient’s own physician
  • high-pressure presentation of a costly intervention
  • use of complex scientific language without supporting clinical evidence

One expert described this style of interaction as “deeply concerning,” particularly when aimed at individuals experiencing chronic pain or injury.


Public interest


This article is based on a verbatim transcript of an undercover telephone call, reviewed as part of an ongoing investigation into the marketing of unproven regenerative treatments.


The purpose of publication is to inform patients, families, and regulators about practices that independent experts say warrant close scrutiny — particularly where medical claims are made without clinical consultation or oversight.


The individuals and organisations referenced have been given an opportunity to respond prior to publication.

This article is published in the public interest.

Recent Posts

May 15, 2026
For months, investigators have examined the digital footprint, corporate structure, public marketing, and leadership profiles connected to Wellbeing International Foundation Ltd.
May 15, 2026
As investigators continued examining the structure behind Wellbeing International Foundation Ltd,
May 10, 2026
WELLBEING INTERNATIONAL FOUNDATION TESTIMONIALS
May 10, 2026
WELLBEING INTERNATIONAL FOUNDATION LTD: “ETHICAL HEALING”
May 3, 2026
The commercial stem cell industry has grown rapidly over the past decade, with clinics around the world advertising regenerative medicine programs for conditions ranging from chronic pain to neurological disorders. Among the most controversial areas is autism. Families searching online are now routinely exposed to clinics promoting stem cell therapies as potential solutions for behavioural, developmental, or communication difficulties associated with autism spectrum disorder (ASD). But according to major medical authorities, parents should be extremely careful before committing to expensive experimental treatments. No Major Regulator Has Approved Stem Cell Therapy For Autism At present: The U.S. Food and Drug Administration has not approved stem cell therapy as a treatment for autism. The National Health Service does not recognise stem cell therapy as a standard autism treatment. European regulators continue treating most autism-related stem cell therapies as experimental. Researchers continue studying the field. But experimental science and established medical treatment are not the same thing. The Problem With Commercial Marketing Critics argue that some clinics blur the line between scientific possibility and proven outcome. Common marketing techniques include: Emotional recovery stories Before-and-after videos Technical medical language Claims of “advanced” therapy References to inflammation or neurological repair However, many scientists say evidence supporting these claims remains limited or inconclusive. Understanding Autism Complexity Autism is not a single illness. It is a broad developmental spectrum involving: Communication differences Behavioural traits Sensory variation Neurological diversity Because autism naturally develops differently in every child, measuring treatment success becomes highly complicated. Experts warn that developmental progress may sometimes occur naturally over time regardless of experimental intervention. What Treatments Have Better Scientific Support? While no treatment cures autism, specialists generally recommend evidence-based support approaches such as: Speech and language therapy Occupational therapy Behavioural intervention Educational support Social development programs Family support services Major organisations providing evidence-based information include: National Autistic Society https://www.autism.org.uk/ Centers for Disease Control and Prevention https://www.cdc.gov/autism/ World Health Organization https://www.who.int/ Autism Speaks https://www.autismspeaks.org/ Questions Families Should Ask Before Paying Experts recommend parents ask: Is this treatment regulator-approved? What peer-reviewed evidence exists? What are the known risks? What percentage of patients show no benefit? Are claims independently verified?  Evidence Before Emotion Families searching for hope deserve compassion, transparency, and honesty. Stem cell science remains an active research field. But until stronger clinical evidence exists, many experts believe autism-related stem cell treatments should be approached with serious caution — particularly when large sums of money and vulnerable families are involved.
May 3, 2026
As commercial stem cell clinics continue expanding across Europe and beyond, increasing numbers of families affected by autism are being introduced to expensive regenerative medicine programs marketed as cutting-edge alternatives to conventional therapy. One organisation repeatedly mentioned during conversations with former clients and concerned families is Wellbeing International Foundation LTD. This article does not accuse the clinic of criminal behaviour or fraud. However, as concerns surrounding commercial autism-related stem cell treatments continue growing internationally, experts say families should approach all such clinics with careful scrutiny. Why Autism Has Become A High-Interest Market Autism spectrum disorder affects millions of families worldwide. Because there is no single cure — and because developmental progress can vary enormously from child to child — families are often vulnerable to treatments marketed as innovative or revolutionary. Investigators reviewing the regenerative medicine sector have identified repeated themes in clinic advertising: Hope-based messaging Emotional testimonials Scientific jargon “Breakthrough” language Claims of advanced neurological repair Large financial commitments For many parents, distinguishing between genuine science and commercial optimism can become extremely difficult. THE MAIN WARNING SIGNS 🚩 Clinics Suggesting One Treatment Can Help Many Conditions Experts urge caution when the same therapy is promoted for: Autism Neurological disease Chronic pain Anti-ageing Immune conditions Degenerative illness Complex medical conditions require highly specific evidence. 🚩 Testimonials Used As Primary Evidence Powerful personal stories can influence emotions deeply. But regulators repeatedly warn that testimonials alone do not prove clinical effectiveness. 🚩 Scientific Terminology Without Clear Proof Families should ask clinics to clearly explain: How treatments work What evidence exists What outcomes are independently verified Complicated language is not the same as scientific certainty. 🚩 Significant Financial Commitments Many families report spending very large sums on: Consultations Treatment programs Flights Accommodation Repeat procedures without guaranteed outcomes. 🚩 Overseas Structures And Limited Oversight International treatment arrangements can complicate: Legal accountability Consumer rights Medical regulation Long-term follow-up The Ethics Of Hope Medical ethics experts have increasingly raised concerns about the emotional vulnerability of families searching for autism support. Parents naturally want to help their children. That emotional reality can make high-promise treatments especially persuasive. Critics argue that hope should never be marketed in a way that risks creating unrealistic expectations.  Questions Families Should Always Ask Before committing to any stem cell-based autism treatment, families should request: Published evidence Independent clinical data Long-term outcomes Full risk disclosures Regulatory status information Transparency matters. Especially when vulnerable families are involved.
May 3, 2026
For many parents raising children with autism, life becomes a constant search for answers. Therapies. Specialists. Diets. Support groups. New research. Alternative medicine. And increasingly, stem cell clinics. Over recent months, Investigations Desk has spoken with families who say they pursued expensive regenerative medicine treatments for autistic children after being exposed to persuasive marketing campaigns promising potential improvements in communication, behaviour, focus, and cognitive function. One parent — who we will identify only as Mr X to protect the child’s privacy — described a journey that began with optimism but eventually turned into doubt. According to Mr X, the family underwent multiple treatment procedures after being encouraged to believe stem cell-based therapies could potentially assist with autism-related symptoms. Initially, every small behavioural change felt significant. But over time, the family says they began questioning whether the treatments had actually produced any measurable improvement at all. “You want to believe something is happening,” Mr X explained. “As a parent, you analyse every little change because you desperately want your child to improve.” The family says the emotional pressure surrounding the process made objective judgment increasingly difficult. The Rise Of Autism As A Commercial Treatment Market Autism spectrum disorder has become one of the fastest-growing target areas within the global regenerative medicine industry. Across websites and social media platforms, clinics frequently advertise: Stem cell therapy Exosome therapy Neuro-regenerative medicine Immune modulation programs Cellular repair treatments Many use emotional testimonials alongside highly technical scientific language which can be difficult for ordinary families to independently verify. Investigators examining this sector have repeatedly identified recurring marketing patterns: Dramatic recovery stories Scientific terminology with limited explanation Expensive treatment packages Overseas treatment arrangements “Breakthrough” medical language Claims that conventional medicine is “behind” What Science Currently Says Despite aggressive online marketing, there is currently no universally accepted regulator-approved stem cell cure for autism. Research into stem cells and neurological conditions does exist. However, leading experts continue warning that experimental research should not be confused with established medical treatment. Autism itself is an extremely complex developmental condition involving a broad spectrum of behavioural and neurological differences. That complexity makes it particularly difficult to scientifically measure treatment claims being promoted commercially. Hope And Vulnerability Parents affected by autism are not foolish for exploring possibilities. They are hopeful. And hope can become extremely powerful when families feel conventional support systems are slow, limited, or overwhelmed. Critics of the commercial stem cell industry argue that some clinics may unintentionally blur the line between experimental science and proven medical outcomes. That concern is now drawing increasing international attention from regulators, scientists, and consumer protection groups.  The Bigger Question Mr X says the family eventually decided to speak privately with investigators after recognising similarities between their experience and concerns now being raised globally about commercial regenerative medicine businesses. “We’re not against research,” he said. “But families need to know the difference between evidence and hope.” That distinction may now sit at the heart of one of the most controversial debates in modern alternative medicine.
April 24, 2026
There is a pattern. Once you’ve seen it, you can’t unsee it.
Show More